XTNT: Xtant Medical Holdings Growth-Adjusted Market Cap to Net Income

Symbol and logo of brand xtantmedical.com (XTNT)

Despite geopolitical pressure on raw material supplies and certification, Xtant Medical Holdings (XTNT) is developing a comprehensive bone regeneration system, establishing a standard for surgeons. The business undervaluation based on the PEG ratio clearly demonstrates this trend, where the parameter is 0.00. The growth of independent distribution in the US and the expansion of the orthopedic clinic base confirm the company's sustainable scaling potential within the biomaterials market.

Xtant Medical Holdings (XTNT) - PEG Multiple from 07/04/2022 to 11/17/2026

Xtant Medical Holdings, Inc. (XTNT) - metric breakdowns and financial figures

- current price and projected stock value:
Fundamental company analysis:XTNT (Xtant Medical Inc)
Manufactured products of Xtant Medical

Xtant Medical Holdings specializes in high-tech implants while adhering to strict waste disposal standards. By analyzing the PEG ratio, an investor compares the market value of the business with its earnings growth. This ratio determines whether the capitalization is fair relative to expansion rates. Values below one signal that the asset is undervalued. This confirms the potential for long-term growth while maintaining controlled environmental costs.

Competing companies

Growth-Adjusted Market Cap to Net Income Boston Scientific|PEG Multiple EW (Edwards)|RMD (ResMed Inc.) - Market Cap to Earnings and Growth Ratio|PODD: Price/Earnings to Growth Multiple|Price to Earnings Adjusted for Growth Rate Zimmer Biomet Corp|COO: PEG Multiple|Price to Earnings Adjusted for Growth Rate Align Technology Inc (ALGN)|GMED (Globus Medical) - PEG Multiple|Growth-Adjusted P/E Ratio TMDX (TransMedics Group Inc)|Price/Earnings to Growth Multiple ATEC (Alphatec)|AORT (CryoLife) - Growth-Adjusted Payback Ratio|Price/Earnings to Growth Ratio Enovis Inc. ENOV|IART - Price/Earnings to Growth Multiple|Establishment Labs Corp - PEG Multiple|Price to Earnings Adjusted for Growth Rate Beta Bionics Inc|IRMD: PEG Multiple|Growth-Adjusted P/E Ratio EMBC|TNDM (Tandem Corp) - PEG Multiple|Axogen Corp (AXGN) - Growth-Adjusted Market Cap to Net Income|PEG Multiple SIBN|Price/Earnings to Growth Multiple Orthofix Medical Inc. OFIX|Price/Earnings to Growth Ratio Bioventus BVS|PEG Multiple OrthoPediatrics Corp. KIDS|TMCI - Price/Earnings to Growth Ratio|SRTA: Price/Earnings to Growth Ratio|CARL (Carlsmed Inc) - Price/Earnings to Growth Multiple|RxSight, Inc. - Growth-Adjusted Payback Ratio|CLPT (ClearPoint Neuro Inc.) - PEG Multiple|Price to Earnings Adjusted for Growth Rate Stereotaxis Inc STXS|Price/Earnings to Growth Ratio Neuronetics Inc. (STIM)|Sight Sciences, Inc. (SGHT) - Price to Net Income Growth Ratio|orchestrabiomed.com - Price/Earnings to Growth Multiple|PEG Multiple Anika ANIK|InspireMD Inc - PEG Multiple|Growth-Adjusted Market Cap to Net Income Jin Medical ZJYL|Vivani Medical (VANI) - Price/Earnings to Growth Ratio|Market Cap to Earnings and Growth Ratio NMTC (NeuroOne Medical Technologies Corp.)|Price/Earnings to Growth Ratio modular-medical.com|Price to Earnings Adjusted for Growth Rate myomo.com MYO|PEG Multiple COCH|VVOS - Price to Earnings Adjusted for Growth Rate|Price/Earnings to Growth Ratio enVVeno Medical NVNO|SINT: Growth-Adjusted P/E Ratio|TNON: Price/Earnings to Growth Multiple|rewalk.com - Company Value to Earnings Growth Ratio|AMIX: PEG Multiple|Growth-Adjusted P/E Ratio IVF|Price/Earnings to Growth Ratio bonebiologics.com|Growth-Adjusted P/E Ratio AXNX (Axonics, Inc)|Price/Earnings to Growth Ratio BIOLASE Inc. (BIOL)|Dynatronics - Growth-Adjusted P/E Ratio|PEG Multiple FNA (Paragon 28 Corp)|invobioscience.com (INVO) - Price to Earnings Adjusted for Growth Rate